Food and Drug Regulations (C.R.C., c. 870)
Full Document:
Regulations are current to 2012-05-14 and last amended on 2012-05-13. Previous Versions
SCHEDULE
(Sections G.01.001 and G.01.004, subsection G.02.014(3), subparagraph G.02.025(1)(b)(iii), subsections G.02.025(3.2) and (4) and G.03.001(3), paragraph G.03.006(a), section G.03.007 and subsection G.05.001(4))
PART I
| 1. | Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, excluding those substances set out in item 1 of the schedule to Part J but including: | |
| (1) | amphetamine (α-methylbenzeneethanamine) | |
| (2) | methamphetamine (N,α-dimethylbenzeneethanamine) | |
| (3) | Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine) | |
| 2. | Methylphenidate (α-phenyl-2-piperidineacetic acid methyl ester) and any salt thereof | |
| 3. | Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)quinazolinone) and any salt thereof | |
| 4. | Phendimetrazine (d-3,4-dimethyl-2-phenylmorpholine) and any salt thereof | |
| 5. | Phenmetrazine (3-methyl-2-phenylmorpholine) and any salt thereof | |
| 6. | Pentobarbital (5-ethyl-5-(1-methylbutyl)barbituric acid) | |
| 7. | Secobarbital (5-allyl-5-(1-methylbutyl)barbituric acid) | |
| 8. | 4-hydroxybutanoic acid (GHB) and any salt thereof | |
| 9. | Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof | |
| 10. | Fenetylline (d,l-3,7-dihydro-1,3-dimethyl-7-(2-[(1-methyl-2-phenethyl)amino]ethyl)-1H-purine-2,6-dione) and any salt thereof | |
| 11. | Glutethimide (2-ethyl-2-phenylglutarimide) | |
| 12. | Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof | |
| 13. | Mecloqualone (2-methyl-3-(2-chlorophenyl)-4(3H)-quinazolinone) and any salt thereof | |
| 14. | Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof | |
| 15. | Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof | |
| 16. | Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof | |
| 17. | Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof | |
PART II
| 1. | Barbiturates, their salts and derivatives, excluding the substances set out in items 6 and 7 of Part I but including: | |
| (1) | Allobarbital (5,5-diallylbarbituric acid) | |
| (2) | Alphenal (5-allyl-5-phenylbarbituric acid) | |
| (3) | Amobarbital (5-ethyl-5-(3-methylbutyl)barbituric acid) | |
| (4) | Aprobarbital (5-allyl-5-isopropylbarbituric acid) | |
| (5) | Barbital (5,5-diethylbarbituric acid) | |
| (6) | Barbituric Acid (2,4,6(1H,3H,5H)-pyrimidinetrione) | |
| (7) | Butabarbital (5-sec-butyl-5-ethylbarbituric acid) | |
| (8) | Butalbital (5-allyl-5-isobutylbarbituric acid) | |
| (9) | Butallylonal (5-(2-bromoallyl)-5-sec-butylbarbituric acid) | |
| (10) | Butethal (5-butyl-5-ethylbarbituric acid) | |
| (11) | Cyclobarbital (5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid) | |
| (12) | Cyclopal (5-allyl-5-(2-cyclopenten-1-yl)barbituric acid) | |
| (13) | Heptabarbital (5-(1-cyclohepten-1-yl)-5-ethylbarbituric acid) | |
| (14) | Hexethal (5-ethyl-5-hexylbarbituric acid) | |
| (15) | Hexobarbital (5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid) | |
| (16) | Mephobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid) | |
| (17) | Methabarbital (5,5-diethyl-1-methylbarbituric acid) | |
| (18) | Methylphenobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid) | |
| (19) | Propallylonal (5-(2-bromoallyl)-5-isopropyl-barbituric acid) | |
| (20) | Phenobarbital (5-ethyl-5-phenylbarbituric acid) | |
| (21) | Probarbital (5-ethyl-5-isopropylbarbituric acid) | |
| (22) | Phenylmethylbarbituric Acid (5-methyl-5-phenylbarbituric acid) | |
| (23) | Sigmodal(5-(2-bromoallyl)-5-(1-methylbutyl)- barbituric acid) | |
| (24) | Talbutal (5-allyl-5-sec-butylbarbituric acid) | |
| (25) | Vinbarbital (5-ethyl-5-(1-methyl-1-butenyl)barbituric acid) | |
| (26) | Vinylbital (5-(1-methylbutyl)-5-vinylbarbituric acid) | |
| 2. | Thiobarbiturates, their salts and derivatives, including: | |
| (1) | Thialbarbital (5-allyl-5-(2-cyclohexen-1-yl)-2-thiobarbituric acid) | |
| (2) | Thiamylal (5-allyl-5-(1-methylbutyl)-2-thiobarbituric acid) | |
| (3) | Thiobarbituric Acid (2-thiobarbituric acid) | |
| (4) | Thiopental(5-ethyl-5-(1-methylbutyl)-2- thiobarbituric acid) | |
| 3. | Chlorphentermine (1-(p-chlorophenyl)-2-methyl-2-aminopropane) and any salt thereof | |
| 4. | Diethylpropion (2-(diethylamino)propiophenone) and any salt thereof | |
| 5. | Phentermine (α,α-dimethylbenzeneethanamine) and any salt thereof | |
| 6. | Butorphanol (1-N-cyclobutylmethyl-3,14-dihydroxy-morphinan) and any salt thereof | |
| 7. | Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and any salt thereof | |
| 8. | Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof | |
PART III
| 1. | Anabolic steroids and their derivatives, including: | |
| (1) | Androisoxazole (17ß-hydroxy-17α-methylandrostano[3,2-c]isoxazole) | |
| (2) | Androstanolone (17ß-hydroxy-5α-androstan-3-one) | |
| (3) | Androstenediol (androst-5-ene-3ß,17ß-diol) | |
| (4) | Bolandiol (estr-4-ene-3b,17ß-diol) | |
| (5) | Bolasterone (17ß-hydroxy-7α,17-dimethylandrost-4-en-3-one) | |
| (6) | Bolazine (17ß-hydroxy-2α-methyl-5α-androstan-3-one azine) | |
| (7) | Boldenone (17ß-hydroxyandrosta-1,4-dien-3-one) | |
| (8) | Bolenol (19-nor-17α-pregn-5-en-17-ol) | |
| (9) | Calusterone (17ß-hydroxy-7b,17-dimethylandrost-4-en-3-one) | |
| (10) | Clostebol (4-chloro-17ß-hydroxyandrost-4-en-3-one) | |
| (11) | Drostanolone (17ß-hydroxy-2α-methyl-5α-androstan-3-one) | |
| (12) | Enestebol (4,17ß-dihydroxy-17-methylandrosta-1,4-dien-3-one) | |
| (13) | Epitiostanol (2α, 3α-epithio-5α-androstan-17ß-ol) | |
| (14) | Ethylestrenol (19-nor-17α-pregn-4-en-17-ol) | |
| (15) | 4-Hydroxy-19-nor testosterone | |
| (16) | Fluoxymesterone (9-fluoro-11ß,17ß-dihydroxy—17-methylandrost-4-en-3-one) | |
| (17) | Formebolone (11α,17ß-dihydroxy-17-methyl-3-oxoandrosta-1,4-dien-2-carboxaldehyde) | |
| (18) | Furazabol (17-methyl-5α-androstano[2,3-c]furazan-17ß-ol) | |
| (19) | Mebolazine (17ß-hydroxy-2α,17-dimethyl-5α-androstan-3-one azine) | |
| (20) | Mesabolone (17ß-[(1-methoxycyclohexyl)oxy]-5α-androst-1-en-3-one) | |
| (21) | Mesterolone (17ß-hydroxy-1α-methyl-5α-androstan-3-one) | |
| (22) | Metandienone (17ß-hydroxy-17-methylandrosta-1,4-dien-3-one) | |
| (23) | Metenolone (17ß-hydroxy-1-methyl-5α-androst-1-en-3-one) | |
| (24) | Methandriol (17α-methylandrost-5-ene-3ß,17ß-diol) | |
| (25) | Methyltestosterone (17ß-hydroxy-17-methyl-androst-4-en-3-one) | |
| (26) | Metribolone (17ß-hydroxy-17-methylestra-4,9,11-trien-3-one) | |
| (27) | Mibolerone (17ß-hydroxy-7α,17-dimethylestr-4-en-3-one) | |
| (28) | Nandrolone (17ß-hydroxyestr-4-en-3-one) | |
| (29) | Norboletone (13-ethyl-17ß-hydroxy-18,19-dinorpregn-4-en-3-one) | |
| (30) | Norclostebol (4-chloro-17ß-hydroxyestr-4-en-3-one) | |
| (31) | Norethandrolone (17α-ethyl-17ß-hydroxyestr-4-en-3-one) | |
| (32) | Oxabolone (4,17ß-dihydroxyestr-4-en-3-one) | |
| (33) | Oxandrolone (17ß-hydroxy-17-methyl-2-oxa-5α-androstan-3-one) | |
| (34) | Oxymesterone (4,17ß-dihydroxy-17-methylandrost-4-en-3-one) | |
| (35) | Oxymetholone (17ß-hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one) | |
| (36) | Prasterone (3ß-hydroxyandrost-5-en-17-one) | |
| (37) | Quinbolone (17ß-(1-cyclopenten-1-yloxy)androsta-1,4-dien-3-one) | |
| (38) | Stanozolol (17ß-hydroxy-17-methyl-5α-androstano[3,2-c]pyrazole) | |
| (39) | Stenbolone (17ß-hydroxy-2-methyl-5α-androst-1-en-3-one) | |
| (40) | Testosterone (17ß-hydroxyandrost-4-en-3-one) | |
| (41) | Tibolone ((7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)en-20-yn-3-one) | |
| (42) | Tiomesterone (1α,7α-bis(acetylthio)-17ß-hydroxy-17-methylandrost-4-en-3-one) | |
| (43) | Trenbolone (17ß-hydroxyestra-4,9,11-trien-3-one) | |
| 2. | Zeranol (3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one) | |
- SOR/78-427, s. 10;
- SOR/79-753, s. 1;
- SOR/81-84, s. 1;
- SOR/85-550, s. 14(F);
- SOR/86-678, s. 1;
- SOR/89-381, s. 1;
- SOR/92-386, s. 3;
- SOR/97-228, s. 21;
- SOR/99-425, s. 1;
- SOR/2003-34, ss. 2, 3;
- SOR/2003-413, s. 2.